Inventor · disambiguated record
Guoxian Wu
Also filed as: WU GUOXIAN
45 granted patents·22 pending applications·2,143 citations·filing 2002–2024
99Inventor score
Top patents by PatentIndex Score
67 records- 0199US9469640B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Oct 18, 2016·44 cites·12 claims
- 0299US7893075B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2007·Granted Feb 22, 2011·96 cites·22 claims
- 0398US9550768B2Kinase modulation and indications thereforPLEXXIKON INC·Filed 2013·Granted Jan 24, 2017·41 cites·6 claims
- 0498US8722702B2Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2013·Granted May 13, 2014·60 cites·16 claims
- 0598US8415469B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 9, 2013·84 cites·18 claims
- 0698US8404700B2Compounds modulating c-fms and/or c-kit activity and uses thereforIBRAHIM PRABHA N·Filed 2012·Granted Mar 26, 2013·63 cites·22 claims
- 0798US8198273B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 12, 2012·65 cites·11 claims
- 0898US7507420B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2005·Granted Mar 24, 2009·148 cites·32 claims
- 0998US7498302B2Disulfide prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2005·Granted Mar 3, 2009·123 cites·32 claims
- 1098US7129261B2Cytotoxic agentsMEDAREX INC·Filed 2002·Granted Oct 31, 2006·282 cites·24 claims
- 1198US7087600B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2002·Granted Aug 8, 2006·259 cites·32 claims
- 1298US6989452B2Disulfide prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2002·Granted Jan 24, 2006·284 cites·21 claims
- 1397US9844539B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 19, 2017·20 cites·30 claims
- 1497US8461169B2Compounds modulating c-fms and/or c-kit activityZHANG JIAZHONG·Filed 2010·Granted Jun 11, 2013·59 cites·32 claims
- 1597US8034959B2Methods of treating cancer with an antibody-drug conjugateMEDAREX INC·Filed 2009·Granted Oct 11, 2011·37 cites·19 claims
- 1697US7846941B2Compounds modulating c-kit and c-fms activity and uses thereforPLEXXIKON INC·Filed 2006·Granted Dec 7, 2010·92 cites·9 claims
- 1796US9440969B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Sep 13, 2016·40 cites·19 claims
- 1896US7977465B2Peptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2009·Granted Jul 12, 2011·14 cites·21 claims
- 1996US7872018B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2007·Granted Jan 18, 2011·48 cites·12 claims
- 2095US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 2195US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 2295US9624213B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA·Filed 2012·Granted Apr 18, 2017·38 cites·4 claims
- 2394US10160755B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 25, 2018·15 cites·14 claims
- 2493US9676748B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 13, 2017·23 cites·20 claims
- 2593US8268858B2Compounds and methods for kinase modulation, and indications thereforWU GUOXIAN·Filed 2007·Granted Sep 18, 2012·49 cites·11 claims
- 2692US10426760B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·6 cites·52 claims
- 2792US9938273B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Apr 10, 2018·17 cites·43 claims
- 2889US7312330B2Bicycloheteroarylamine compounds as ion channel ligands and uses thereofRENOVIS INC·Filed 2005·Granted Dec 25, 2007·8 cites·38 claims
- 2988US10703757B2Compounds and methods for CDK8 modulation and indications thereforPLEXXIKON INC·Filed 2017·Granted Jul 7, 2020·4 cites·38 claims
- 3088US10428067B2Compounds and methods for kinase modulationPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·8 cites·18 claims
- 3188US10301280B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 28, 2019·6 cites·21 claims
- 3287US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 3385US10508085B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 17, 2019·6 cites·37 claims
- 3485USRE41252EPeptidyl prodrugs and linkers and stabilizers useful thereforMEDAREX INC·Filed 2008·Granted Apr 20, 2010·3 cites·32 claims
- 3585US7338950B2Amide compounds as ion channel ligands and uses thereofRENOVIS INC·Filed 2004·Granted Mar 4, 2008·18 cites·30 claims
- 3685US2025195516A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2024·Application pending·0 cites
- 3784US10519177B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 31, 2019·4 cites·22 claims
- 3884US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 3984US7576099B2Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the sameRENOVIS INC·Filed 2006·Granted Aug 18, 2009·5 cites·24 claims
- 4083US12076322B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 4180US11149011B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2019·Granted Oct 19, 2021·2 cites·23 claims
- 4280US2021353602A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 4380US2021346358A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 4477US11337976B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 24, 2022·1 cites·10 claims
- 4572US11446287B2Compounds and methods for EP300 or CBP modulation and indications thereforOPNA IMMUNO ONCOLOGY SA·Filed 2020·Granted Sep 20, 2022·1 cites·37 claims
- 4670US2019209536A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2018·Application pending·0 cites
- 4769US2010190777A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2008·Application pending·0 cites
- 4868US2019263800A1Compounds modulating c-fms and/or c-kit activity and uses thereforPLEXXIKON INC·Filed 2018·Application pending·0 cites
- 4968US2014303187A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Application pending·0 cites
- 5067US2017319559A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Guoxian Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →